Transplantable dopamine neurons produced from stem cells could expedite treatment options for Parkinson's disease.
Transplanted dopamine neurons from fetal tissues remained healthy in the brains of people with Parkinson's disease for 14 years.
Researchers transplanted neural cells, derived from adult skin cells, into monkeys; where they developed into several different types of brain cells. The research could eventually help provide new treatment avenues for patients with a wide range of neurological diseases.
Researchers identify a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson’s disease. The study implicates two genetic variants that disrupt protein sorting in neurons.